Position in ARGX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$62,314,421
+$48,542,185 QoQ
Shares Held
85,333
+421.1% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 99.60273282317509.ToString("F0")%
Shared 0.ToString("F0")%
None 0.39726717682490953.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF MONTREAL /CAN/ holds $580,215,891 across 80 Biotechnology names. ARGX ranks #4 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,476 | $174,363,150 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,055,597 | $68,223,231 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
85,524 | $66,079,260 | |
| 4 | ARGX |
Argenx SE
This page
|
85,333 | $62,314,421 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
239,265 | $45,233,045 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
86,183 | $17,206,434 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
515,328 | $17,119,195 | |
| 8 | INCY |
Incyte Corp
|
171,790 | $16,168,871 |
All Filings in ARGX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $62,314,421 | 85,333 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $13,772,236 | 16,377 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $7,601,291 | 10,306 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,199,657 | 9,433 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $5,506,118 | 9,303 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,680,140 | 9,236 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,503,058 | 8,307 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,265,291 | 7,593 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,148,869 | 23,237 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $10,259,434 | 26,968 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $15,798,526 | 32,135 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $18,241,700 | 46,806 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $11,156,162 | 29,943 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $24,138,668 | 63,719 | Shares | Defined | 2023-02-01 | |
| 2021-03-31 | $42,960 | 156 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $26,174 | 89 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $19,951 | 76 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||